Editorial: Unrefined antihistamine lode.
D000380:Agranulocytosis / Q000139:chemically induced; D003864:Depression, Chemical; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000628:therapy; D005750:Gastric Juice / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D011955:Receptors, Drug / Q000187:drug effects; D013440:Sulfides / Q000009:adverse effects / Q000627:therapeutic use; D013890:Thiourea / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D006634:Histamine H1 Antagonists; D007093:Imidazoles; D011955:Receptors, Drug; D013440:Sulfides; D013890:Thiourea